demonstrates that initiating ruxolitinib cream therapy for atopic dermatitis (AD) significantly reduced patients’ reliance on other topical treatments, oral corticosteroids, and biologics in ...

Raj Chovatiya, MD, PhD, MSCI, highlights promising research in atopic dermatitis focused on identifying patient subgroups for targeted treatments and achieving long-term remission. Raj Chovatiya ...

In a post-hoc analysis, dupilumab improved symptoms of atopic dermatitis (AD) in young children ages 6 months to 5 years. Youngsters with associated comorbidities such as asthma, allergic rhinitis ...

Ivarmacitinib, a selective oral Janus kinase 1 inhibitor, significantly improved signs and symptoms in patients with moderate to severe atopic dermatitis (AD) and showed a favorable safety profile ...

Red, itchy, and scaly skin from atopic dermatitis and eczema can be uncomfortable, confusing, and all too familiar. These ...

In this video, Peter Lio, MD, discussed updates on topical agents, biologics and drugs in the pipeline in atopic dermatitis from presentations at the American Academy of Dermatology meeting.

Researchers conducted a systematic review of 16 studies on the menstrual cycle and AD, following Preferred Reporting Items for Systematic reviews and Meta-Analysis guidelines. The literature ...

The atopic dermatitis app will launch first in the UK, followed by Belgium, Norway, the Netherlands, Sweden, France, Ireland, and Japan later in 2022. Image Phil Taylor ...

What I Wish I Knew Sooner About How People Really View My Eczema What I Wish I Knew About the Victim-Blaming I’d Face by Scratching My Atopic Dermatitis What I Wish I Knew About Atopic ...

Approval in atopic dermatitis could unlock additional sales momentum for Zoryve, which is available in a 0.3% cream for psoriasis and a 0.3% topical foam for seborrheic dermatitis. Those ...

receptor pathway in moderate to severe atopic dermatitis (AD). SM17 uniquely binds to the co-receptor for IL-25, a key alarmin, and blocks downstream signaling - disrupting the inflammatory ...